Literature DB >> 20024943

Additive survival least-squares support vector machines.

V Van Belle1, K Pelckmans, J A K Suykens, S Van Huffel.   

Abstract

This work studies a new survival modeling technique based on least-squares support vector machines. We propose the use of a least-squares support vector machine combining ranking and regression. The advantage of this kernel-based model is threefold: (i) the problem formulation is convex and can be solved conveniently by a linear system; (ii) non-linearity is introduced by using kernels, componentwise kernels in particular are useful to obtain interpretable results; and (iii) introduction of ranking constraints makes it possible to handle censored data. In an experimental setup, the model is used as a preprocessing step for the standard Cox proportional hazard regression by estimating the functional forms of the covariates. The proposed model was compared with different survival models from the literature on the clinical German Breast Cancer Study Group data and on the high-dimensional Norway/Stanford Breast Cancer Data set.

Entities:  

Mesh:

Year:  2010        PMID: 20024943     DOI: 10.1002/sim.3743

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Support Vector Hazards Machine: A Counting Process Framework for Learning Risk Scores for Censored Outcomes.

Authors:  Yuanjia Wang; Tianle Chen; Donglin Zeng
Journal:  J Mach Learn Res       Date:  2016-08-01       Impact factor: 3.654

2.  Survival Prediction and Feature Selection in Patients with Breast Cancer Using Support Vector Regression.

Authors:  Shahrbanoo Goli; Hossein Mahjub; Javad Faradmal; Hoda Mashayekhi; Ali-Reza Soltanian
Journal:  Comput Math Methods Med       Date:  2016-11-01       Impact factor: 2.238

3.  Enhancing SVM for survival data using local invariances and weighting.

Authors:  Hector Sanz; Ferran Reverter; Clarissa Valim
Journal:  BMC Bioinformatics       Date:  2020-05-19       Impact factor: 3.169

4.  γ -H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer.

Authors:  E Chatzimichail; D Matthaios; D Bouros; P Karakitsos; K Romanidis; S Kakolyris; G Papashinopoulos; A Rigas
Journal:  Int J Genomics       Date:  2014-01-08       Impact factor: 2.326

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.